| Literature DB >> 31543895 |
Jonathan Dahlin1, Carina Holkenbrink1, Eko Roy Marella1, Guokun Wang1, Ulf Liebal2, Christian Lieven1, Dieter Weber2, Douglas McCloskey1, Birgitta E Ebert2, Markus J Herrgård1, Lars Mathias Blank2, Irina Borodina1.
Abstract
Fatty alcohols are widely used in various applications within a diverse set of industries, such as the soap and detergent industry, the personal care, and cosmetics industry, as well as the food industry. The total world production of fatty alcohols is over 2 million tons with approximately equal parts derived from fossil oil and from plant oils or animal fats. Due to the environmental impact of these production methods, there is an interest in alternative methods for fatty alcohol production via microbial fermentation using cheap renewable feedstocks. In this study, we aimed to obtain a better understanding of how fatty alcohol biosynthesis impacts the host organism, baker's yeast Saccharomyces cerevisiae or oleaginous yeast Yarrowia lipolytica. Producing and non-producing strains were compared in growth and nitrogen-depletion cultivation phases. The multi-omics analysis included physiological characterization, transcriptome analysis by RNAseq, 13Cmetabolic flux analysis, and intracellular metabolomics. Both species accumulated fatty alcohols under nitrogen-depletion conditions but not during growth. The fatty alcohol-producing Y. lipolytica strain had a higher fatty alcohol production rate than an analogous S. cerevisiae strain. Nitrogen-depletion phase was associated with lower glucose uptake rates and a decrease in the intracellular concentration of acetyl-CoA in both yeast species, as well as increased organic acid secretion rates in Y. lipolytica. Expression of the fatty alcohol-producing enzyme fatty acyl-CoA reductase alleviated the growth defect caused by deletion of hexadecenal dehydrogenase encoding genes (HFD1 and HFD4) in Y. lipolytica. RNAseq analysis showed that fatty alcohol production triggered a cell wall stress response in S. cerevisiae. RNAseq analysis also showed that both nitrogen-depletion and fatty alcohol production have substantial effects on the expression of transporter encoding genes in Y. lipolytica. In conclusion, through this multi-omics study, we uncovered some effects of fatty alcohol production on the host metabolism. This knowledge can be used as guidance for further strain improvement towards the production of fatty alcohols.Entities:
Keywords: 13C-fluxome; Saccharomyces cerevisiae; Yarrowia lipolytica; fatty alcohol; metabolome; transcriptome
Year: 2019 PMID: 31543895 PMCID: PMC6730484 DOI: 10.3389/fgene.2019.00747
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Figure 1Fatty alcohol biosynthesis via fatty acyl–CoA reductase (FAR). FAR catalyzes the conversion of fatty acyl–CoAs to fatty alcohols with the fatty aldehyde as transient intermediate (indicated as brackets). The substrate depicted in the figure is hexadecanoyl-CoA; however, carbon chain length and saturation may vary.
Strains used in this study.
| Name | ID | Genotype | Reference |
|---|---|---|---|
|
| CEN.PK113-7D |
|
|
|
| ST6849 | pex10Δ, hfd1Δ, MATa | This study |
|
| ST6989 |
| This study |
|
| W29 | MATa |
|
|
| ST6770 | pex10Δ, fao1Δ, hfd1Δ, hfd4Δ, | This study |
|
| ST6987 |
| This study |
Figure 2Pathway for fatty alcohol production; a simplified pathway for the metabolic conversion of glucose into fatty alcohols in S. cerevisiae and Y. lipolytica. Color-coded text and arrows: red, pathway in Saccharomyces cerevisiae; blue, pathway in Yarrowia lipolytica; green, heterologous reactions. The red X-symbol signifies corresponding gene knockouts. Abbreviations: ACL, ATP citrate lyase; ACS, acetyl–CoA synthase; ACC, acetylCoA carboxylase; FAS, fatty acid synthase complex; FAR, fatty acyl–CoA reductase; PEX10, peroxin 10; FAO1, fatty alcohol oxidase; HFD1, fatty aldehyde dehydrogenase 1 (ALDH1); HFD4, fatty aldehyde dehydrogenase 4 (ALDH4).
Figure 3Fatty alcohol degradation and production (A) Fatty alcohol degradation was estimated by cultivating yeast strains in the presence of extracellular fatty alcohol mixture consisting of hexadecanol (C16-OH) and octadecanol (C18-OH) and quantifying the residual concentrations. (B) Production of fatty alcohols by engineered strains of S. cerevisiae and Y. lipolytica on minimal medium after 96 h, nd: not detected. Data shown are mean values ± standard deviations of biological triplicates.
Figure 4Strain growth in minimal media and nitrogen-depleted media; Growth curves of S. cerevisiae (A, C) and Y. lipolytica strains (B, D) on minimal media (A, B) and nitrogen-depletion media (C, D). Pre-cultures were grown on minimal media until the late exponential phase, and subsequently washed and resuspended in either fresh minimal media or in nitrogen-depletion media. Data shown are mean values ± standard deviations of biological triplicates. Sc, accharomyces erevisiae; Yl, arrowia ipolytica, Pr, fatty alcohol producing; Np, non-producing; Gr, growth phase; Ni, nitrogen-depleted stationary phase.
Uptake-, secretion-, and growth rate. Sc, accharomyces erevisiae; Yl, arrowia ipolytica, Pr, fatty alcohol producing; Np, non-producing; Gr, growth phase; Ni, nitrogen-depleted stationary phase; nd, not determined. Data shown are mean values ± standard deviations of biological triplicates.
| Glucose | Ethanol | Acetate | Glycerol | Succinate | Malate | Isocitrate | |
|---|---|---|---|---|---|---|---|
| mmol g−1 h−1 | mmol g−1 h−1 | mmol g−1 h−1 | mmol g−1 h−1 | µmol g−1 h−1 | µmol g−1 h−1 | µmol g−1 h−1 | |
|
| 15.7 ± 0.29 | 22. ± 0.3 | 1.41 ± 0.1 | 2.81 ± 0.0 | nd | nd | nd |
|
| 15.4 ± 0.26 | 20.6 ± 0.4 | 2.3 ± 0.3 | 3.89 ± 0.3 | nd | nd | nd |
|
| 1.17 ± 0.12 | 0.9 ± 0.5 | 0.2 ± 0.0 | 0.0 ± 0.0 | nd | nd | nd |
|
| 1.61 ± 0.10 | 2.4 ± 0.9 | 0.1 ± 0.0 | 0.3 ± 0.0 | nd | nd | nd |
|
| 1.52 ± 0.19 | nd | nd | nd | 1.2 ± 0.4 | 8.3 ± 1.9 | 1.1 ± 0.1 |
|
| 2.04 ± 0.20 | nd | nd | nd | 0.8 ± 0.0 | 5.5 ± 0.2 | 0.4 ± 0.0 |
|
| 0.35 ± 0.01 | nd | nd | nd | 5.0 ± 0.7 | 31.3 ± 3.8 | 6.6 ± 1.2 |
|
| 0.22 ± 0.03 | nd | nd | nd | 1.8 ± 0.3 | 9.1 ± 0.6 | 0.2 ± 0.5 |
|
|
|
|
|
|
| ||
| µmol g−1 h−1 | µmol g−1 h−1 | µmol g−1 h−1 | µmol g−1 h−1 | µmol g−1 h−1 | h−1 | ||
|
| nd | nd | nd | nd | nd | 0.33 ± 0.00 | |
|
| nd | nd | nd | nd | nd | 0.17 ± 0.00 | |
|
| nd | nd | nd | nd | nd | nd | |
|
| nd | nd | nd | nd | 1.9 ± 0.7 | nd | |
|
| 1.1 ± 0.8 | 30.2 ± 3.9 | 1.7 ± 0.4 | 79.7 ± 8.9 | nd | 0.13 ± 0.00 | |
|
| 0.6 ± 0.1 | 11.9 ± 0.9 | 1.0 ± 0.1 | 33.2 ± 5.0 | nd | 0.12 ± 0.00 | |
|
| 54.9 ± 3.2 | 39.1 ± 13.4 | 7.2 ± 1.4 | 102.7 ± 5.4 | nd | nd | |
|
| 12.6 ± 1.2 | 19.9 ± 2.2 | 1.3 ± 0.1 | 29.9 ± 2.7 | 6.0 ± 0.9 | nd |
Figure 5Fluxes and metabolite levels in central carbon metabolism. Fluxes (gray boxes) are relative values, defined as the percentage of glucose uptake rate. Negative values indicate that the reaction is taking place in the opposite direction to what is indicated by the arrow. Metabolites (heatmaps) correspond to absolute abundances in µmol/g CDW; gray means data missing (below the detection limit, saturated signal, or too high background in control sample). Sc: accharomyces erevisiae, Yl: arrowia ipolytica, Pr: fatty alcohol producing, Np: non-producing, Gr: growth phase, Ni: nitrogen-depleted stationary phase.
Figure 6Principal component analysis of transcriptomic data; PCA scatterplot showing S. cerevisiae RNA-seq samples projected onto the first two principal components of the data (A). PCA scatterplot showing Y. lipolytica RNA-seq samples projected onto the first two principal components of the data (B). Sc, accharomyces erevisiae; Yl, arrowia ipolytica; Pr, fatty alcohol producing; Np, non-producing; G, growth phase; Ni, nitrogen-depleted stationary phase.
GO term enrichment in differentially expressed genes. Go terms enriched more than 2.5-fold. Indented GO terms in brackets are a sub-group of the preceeding broader higher-level GO term. Differentially expressed genes described as condition 1 vs. condition 2, where upregulated signifies that condition 1 has a higher transcript abundance, and downregulated signifies that condition 2 has a higher transcript abundance. Uncharacterized genes consist of unclassified or unknown genes.
|
| ||||
|---|---|---|---|---|
| Total: 401 genes, uncharacterized: 70 genes | ||||
|
|
|
|
|
|
| Glyoxylate metabolic process (GO:0046487) | 6 | 0.6 |
| 9.60E-05 |
| Oligopeptide transmembrane transport (GO:0035672) | 5 | 0.5 |
| 5.00E-04 |
| Glutamate metabolic process (GO:0006536) | 6 | 0.9 |
| 8.90E-04 |
| Antibiotic metabolic process (GO:0016999) | 18 | 3.4 |
| 8.70E-08 |
| [Tricarboxylic acid cycle (GO:0006099)] | 11 | 1.6 |
| 4.80E-06 |
|
| 7 | 1.3 |
| 8.50E-04 |
| Ammonium transport (GO:0015696) | 6 | 1.2 |
| 2.20E-03 |
| Carbohydrate biosynthetic process (GO:0016051) | 17 | 3.5 |
| 4.80E-07 |
| Monosaccharide metabolic process (GO:0005996) | 16 | 3.7 |
| 4.10E-06 |
| Carbohydrate catabolic process (GO:0016052) | 20 | 4.7 |
| 3.10E-07 |
| Response to toxic substance (GO:0009636) | 15 | 3.8 |
| 2.50E-05 |
| Monocarboxylic acid metabolic process (GO:0032787) | 35 | 3.8 |
| 1.50E-10 |
| Carbohydrate metabolic process (GO:0005975) | 50 | 13.2 |
| 1.70E-14 |
| Small molecule catabolic process (GO:0044282) | 30 | 8 |
| 5.00E-09 |
| Response to oxidative stress (GO:0006979) | 25 | 6.6 |
| 8.00E-08 |
| Cellular glucan metabolic process (GO:0006073) | 11 | 3 |
| 4.50E-04 |
| Oxidation-reduction process (GO:0055114) | 75 | 24.1 |
| 2.30E-17 |
| [Carboxylic acid catabolic process (GO:0046395)] | 15 | 4.8 |
| 2.20E-04 |
| [Fatty acid beta-oxidation (GO:0006635)] | 7 | 0.7 |
| 2.80E-05 |
| Response to heat (GO:0009408) | 15 | 4.9 |
| 2.70E-04 |
| Drug metabolic process (GO:0017144) | 43 | 15.3 |
| 6.10E-09 |
| Cellular response to external stimulus (GO:0071496) | 18 | 6.7 |
| 3.30E-04 |
| Nucleobase-containing small molecule metabolic process (GO:0055086) | 41 | 15.7 |
| 9.80E-08 |
| [Nucleotide metabolic process (GO:0009117)] | 34 | 13.6 |
| 3.00E-06 |
| Cofactor metabolic process (GO:0051186) | 37 | 14 |
| 4.20E-07 |
| Coenzyme metabolic process (GO:0006732) | 26 | 10.3 |
| 5.00E-05 |
| [Glycolytic process (GO:0006096)] | 7 | 1.4 |
| 1.30E-03 |
|
|
| |||
| Total: 315 genes, uncharacterized: 29 genes | ||||
|
|
|
|
|
|
| S-adenosylmethionine metabolic process (GO:0046500) | 5 | 0.3 |
| 1.20E-04 |
| Regulation of establishment or maintenance of cell polarity (GO:0032878) | 4 | 0.3 |
| 1.10E-03 |
| Nucleobase biosynthetic process (GO:0046112) | 7 | 1.1 |
| 2.70E-04 |
| DNA integration (GO:0015074) | 14 | 2.4 |
| 8.80E-07 |
| rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428) | 14 | 3.1 |
| 8.90E-06 |
| Ribosomal small subunit biogenesis (GO:0042274) | 28 | 7 |
| 3.60E-09 |
| DNA biosynthetic process (GO:0071897) | 16 | 4.7 |
| 4.90E-05 |
| Amide biosynthetic process (GO:0043604) | 65 | 20.3 |
| 6.40E-16 |
| [Translation (GO:0006412)] | 61 | 17.7 |
| 3.10E-16 |
| Transposition, RNA-mediated (GO:0032197) | 14 | 4.4 |
| 3.00E-04 |
| Ribosomal large subunit biogenesis (GO:0042273) | 18 | 5.9 |
| 6.90E-05 |
| Cellular amino acid metabolic process (GO:0006520) | 37 | 12.3 |
| 1.10E-08 |
| RNA phosphodiester bond hydrolysis (GO:0090501) | 27 | 9.1 |
| 1.70E-06 |
| Cellular amide metabolic process (GO:0043603) | 69 | 23.6 |
| 4.30E-15 |
| Nucleoside phosphate biosynthetic process (GO:1901293) | 19 | 7.4 |
| 3.10E-04 |
|
| ||||
|
| ||||
| Total: 21 genes, uncharacterized: four genes | ||||
|
|
|
|
|
|
| Cell wall organization or biogenesis (GO:0071554) | 9 | 0.8 |
| 7.2E-05 |
|
|
|
|
|
|
| Total: three genes, uncharacterized: three genes | ||||
|
|
|
|
|
|
| None | – | – | – | – |
|
| ||||
|
|
|
|
|
|
| Total: 500 genes, uncharacterized: 355 genes | ||||
|
|
|
|
|
|
| Transmembrane transport (GO:0055085) | 70 | 20.6 |
| 2.8E-18 |
| [Ammonium transmembrane transport (GO:0072488)] | 9 | 0.6 |
| 1.7E-07 |
| [Carboxylic acid transmembrane transport (GO:1905039)] | 11 | 2.3 |
| 5.1E-05 |
| [Amino acid transmembrane transport (GO:0003333)] | 11 | 1.6 |
| 3.6E-06 |
|
|
|
|
|
|
| Total: 131 genes, uncharacterized: 54 genes | ||||
|
|
|
|
|
|
| Sulfur compound metabolic process (GO:0006790) | 13 | 1.8 |
| 6.9E-08 |
|
| ||||
|
|
|
|
|
|
| Total: 60 genes, uncharacterized: 21 genes | ||||
|
|
|
|
|
|
| Antibiotic catabolic process (GO:0017001) | 6 | 0.1 |
| 1.57E-08 |
| [Formate catabolic process (GO:0042183)] | 4 | 0.1 |
| 1.59E-06 |
|
|
|
|
|
|
| Total: 155 genes, uncharacterized: 79 genes | ||||
|
|
|
|
|
|
| Transport (GO:0006810) | 51 | 16.5 |
| 2.2E-11 |
| [Nitrogen compound transport (GO:0071705)] | 26 | 7.7 |
| 6.8E-05 |
| [Carboxylic acid transmembrane transport (GO:1905039)] | 11 | 1.3 |
| 1.7E-04 |
| [Amino acid transmembrane transport (GO:0003333)] | 10 | 0.8 |
| 4.3E-05 |